This position will support rare disease–focused cell therapy programs, distinct from traditional oncology CAR‐T development. The scientific focus is on non‐malignant, genetically defined, or ultra‐rare indications, where therapeutic goals, experimental…

This position will support rare disease–focused cell therapy programs, distinct from traditional oncology CAR‑T development. The scientific focus is on non‑malignant, genetically defined, or ultra‑rare indications, where therapeutic goals, experimental…

This position will support rare disease–focused cell therapy programs, distinct from traditional oncology CAR‑T development. The scientific focus is on non‑malignant, genetically defined, or ultra‑rare indications, where therapeutic goals, experimental…